Big Pharma Racks Up Facebook Likes But Not So Much from Patients
In this 2.5-minute audio snippet, Pharmaguy contemplates how big drug companies can get hundreds of thousands of "likes" on Facebook but score very low among patient groups worldwide. Only 25% of patients, for example, think pharma marketing is ethical. A case in point is Low-T direct-to-consumer advertising.
For more about these issues and links to further reading, read this article published on LinkedIn: